ORAGENICS INC (OGEN) Forecast, Price Target & Analyst Ratings
NYSEARCA:OGEN • US6840236094
0.88 USD
+0.02 (+2.33%)
Last: Mar 5, 2026, 04:03 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ORAGENICS INC (OGEN).
Forecast Snapshot
Consensus Price Target
$2.04
+ 131.82% Upside
Next Earnings Forecast
Release DateMar 12, 2026
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$2.04
Upside
+ 131.82%
From current price of $0.88 to mean target of $2.04, Based on 7 analyst forecasts
Low
$2.02
Median
$2.04
High
$2.10
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 analysts have analysed OGEN and the average price target is 2.04 USD. This implies a price increase of 131.82% is expected in the next year compared to the current price of 0.88.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
OGEN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about OGEN.
In the previous month the buy percentage consensus was at a similar level.
OGEN was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-06-03 | Goldman Sachs | Initiate | Neutral |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 12, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 90K | 130K 44.44% | 37.7K -71.00% | -100.00% | N/A | N/A | ||||
| EBITDA YoY % growth | -15.73M 40.84% | -14.38M 8.58% | -20.878M -45.18% | -9.823M 52.95% | -13.45M -36.93% | -13.45M | -20.75M -54.28% | N/A | N/A | |
| EBIT YoY % growth | -15.77M 40.80% | -14.42M 8.56% | -20.905M -44.97% | -9.835M 49.49% | -13.462M -27.50% | -20.762M -54.23% | -20.983M -1.07% | N/A | N/A | |
| Operating Margin | -17,522.22% | -11,092.31% | -55,450.66% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -252.00 70.83% | -202.50 19.64% | N/A 94.56% | -23.26 -111.11% | -0.78 96.67% | -0.70 9.21% | -0.43 39.13% | -0.40 7.14% | 0.30 174.36% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.60%
EPS Next 5 Year
15.02%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-28.26%
EBIT Next 5 Year
N/A
ORAGENICS INC / OGEN Forecast FAQ
What is the price target for OGEN stock?
7 analysts have analysed OGEN and the average price target is 2.04 USD. This implies a price increase of 131.82% is expected in the next year compared to the current price of 0.88.
Can you provide the upcoming earnings date for ORAGENICS INC?
ORAGENICS INC (OGEN) will report earnings on 2026-03-12, after the market close.